Advanzeon Solutions, Inc. (CHCR) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Advanzeon Solutions, Inc. (CHCR) ist im Healthcare-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Bewertet mit 46/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 16. März 2026Advanzeon Solutions, Inc. (CHCR) Gesundheitswesen & Pipeline-Uebersicht
Advanzeon Solutions, Inc. operates in the healthcare sector, focusing on sleep apnea program administration through its SleepMaster Solutions. Currently trading on the OTC market after a Chapter 11 filing, the company faces challenges in a competitive medical care facilities landscape.
Investmentthese
Investing in Advanzeon Solutions, Inc. (CHCR) presents significant risks due to its OTC market listing and recent Chapter 11 bankruptcy filing in 2020. The company's reliance on the SleepMaster Solutions program for revenue makes it vulnerable to market shifts and competition. With a market capitalization of $0.00B and a beta of 1.24, CHCR exhibits high volatility. Potential investors should closely monitor the company's restructuring efforts and ability to regain financial stability. Growth catalysts are uncertain, and the company's future depends on successfully navigating its bankruptcy proceedings and re-establishing a competitive position in the healthcare sector.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Advanzeon Solutions, Inc. operates the SleepMaster Solutions sleep apnea program.
- The company filed for Chapter 11 bankruptcy on September 7, 2020.
- CHCR trades on the OTC market, indicating higher risk and lower liquidity.
- The company's market capitalization is $0.00B, reflecting its distressed financial state.
- The company's beta is 1.24, indicating higher volatility than the market.
Wettbewerber & Vergleichsunternehmen
Staerken
- Specialized SleepMaster Solutions program.
- Experience in sleep apnea program administration.
- Established presence in the healthcare sector.
- Focus on a specific medical condition.
Schwaechen
- Recent Chapter 11 bankruptcy filing.
- OTC market listing indicating higher risk.
- Limited market capitalization.
- Reliance on a single product line.
Katalysatoren
- Upcoming: Successful restructuring and emergence from Chapter 11 bankruptcy could restore investor confidence.
- Ongoing: Expansion of the SleepMaster Solutions program into new markets could drive revenue growth.
- Ongoing: Strategic partnerships with healthcare providers could enhance market penetration.
Risiken
- Ongoing: Financial instability due to Chapter 11 bankruptcy.
- Potential: Intense competition in the medical care facilities industry.
- Potential: Regulatory changes and reimbursement pressures.
- Ongoing: Limited liquidity and high volatility due to OTC market listing.
- Potential: Dependence on a single product line (SleepMaster Solutions).
Wachstumschancen
- Expansion of Sleep Apnea Program: Advanzeon could focus on expanding its SleepMaster Solutions program by targeting new geographic markets and patient demographics. The global sleep apnea devices market is projected to reach $5.2 billion by 2027, offering a substantial growth opportunity. Success depends on effective marketing, strategic partnerships, and demonstrating superior patient outcomes.
- Telehealth Integration: Integrating telehealth services into the SleepMaster Solutions program could enhance accessibility and convenience for patients, particularly in remote areas. The telehealth market is experiencing rapid growth, driven by technological advancements and increasing demand for remote healthcare solutions. This integration could improve patient engagement and reduce operational costs.
- Strategic Partnerships: Forming strategic alliances with healthcare providers, insurance companies, and sleep clinics could expand Advanzeon's reach and market penetration. Partnerships can provide access to new patient referrals, distribution channels, and reimbursement opportunities. Successful partnerships require alignment of goals, clear communication, and mutual benefit.
- Product Diversification: Diversifying beyond sleep apnea treatment into related respiratory care services could broaden Advanzeon's revenue streams and reduce its reliance on a single product line. This could include offering diagnostic services, respiratory therapy, and home healthcare solutions. Diversification requires careful market research, investment in new technologies, and skilled personnel.
- Cost Optimization: Implementing cost-saving measures and streamlining operations could improve Advanzeon's financial performance and enhance its competitiveness. This includes optimizing supply chain management, reducing administrative expenses, and improving operational efficiency. Cost optimization is crucial for companies facing financial challenges and can improve profitability and cash flow.
Chancen
- Expansion into new geographic markets.
- Integration of telehealth services.
- Strategic partnerships with healthcare providers.
- Diversification into related respiratory care services.
Risiken
- Intense competition in the medical care facilities industry.
- Regulatory changes and reimbursement pressures.
- Potential for product obsolescence.
- Economic downturn affecting patient affordability.
Wettbewerbsvorteile
- Proprietary SleepMaster Solutions program.
- Established relationships with healthcare providers.
- Experience in sleep apnea program administration.
- Focus on specialized care services.
Ueber CHCR
Advanzeon Solutions, Inc., formerly known as Comprehensive Care Corporation, was established in 1969 and rebranded in January 2014. Headquartered in Tampa, Florida, the company operates through its subsidiary, Pharmacy Value Management Solutions, Inc., which administers and manages the SleepMaster Solutions program, a sleep apnea treatment service. Advanzeon's core business revolves around providing solutions for individuals suffering from sleep apnea, a prevalent condition affecting millions. However, on September 7, 2020, Advanzeon Solutions, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida, impacting its operational and financial stability. The company's long-term viability hinges on its ability to restructure and regain market confidence while navigating the competitive landscape of the medical care facilities industry.
Was das Unternehmen tut
- Administers and operates the SleepMaster Solutions sleep apnea program.
- Provides solutions for individuals suffering from sleep apnea.
- Operates through its subsidiary, Pharmacy Value Management Solutions, Inc.
- Offers sleep apnea treatment services.
- Focuses on managing sleep apnea programs.
- Aims to improve the quality of life for sleep apnea patients.
Geschaeftsmodell
- Generates revenue through the SleepMaster Solutions program.
- Provides sleep apnea treatment services to patients.
- Partners with healthcare providers and insurance companies.
- Focuses on program administration and management.
Branchenkontext
Advanzeon Solutions, Inc. operates within the medical care facilities industry, a segment of the broader healthcare sector. This industry is characterized by increasing demand for specialized care services, including sleep apnea treatment. However, the competitive landscape is intense, with established players and emerging technologies vying for market share. Advanzeon's position is challenged by its recent bankruptcy filing and the need to restructure its operations. The industry is also subject to regulatory changes and reimbursement pressures, further impacting the company's prospects.
Wichtige Kunden
- Individuals suffering from sleep apnea.
- Healthcare providers and sleep clinics.
- Insurance companies covering sleep apnea treatment.
- Patients seeking solutions for sleep-related breathing disorders.
Finanzdaten
Chart & Info
Advanzeon Solutions, Inc. (CHCR) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer CHCR verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer CHCR.
Kursziele
Wall-Street-Kurszielanalyse fuer CHCR.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von CHCR auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Clark A. Marcus
Managing Director
Clark A. Marcus serves as the Managing Director of Advanzeon Solutions, Inc. His role involves overseeing the company's operations and strategic direction. Information on his prior experience and education is not available. As the managing director, he is responsible for the overall performance and management of the company, particularly during its restructuring phase following the Chapter 11 filing.
Erfolgsbilanz: Due to limited information available, Clark A. Marcus's specific achievements and strategic decisions at Advanzeon Solutions, Inc. are unknown. His tenure is marked by the company's Chapter 11 bankruptcy filing in 2020, indicating significant challenges during his leadership. Evaluating his long-term impact requires further information on the company's restructuring efforts and future performance.
CHCR OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that Advanzeon Solutions, Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited reporting requirements and may be undergoing financial distress or restructuring. Unlike NYSE or NASDAQ-listed companies, OTC Other stocks generally have less stringent listing requirements, leading to increased risk and volatility for investors. This tier signifies a higher level of caution is warranted due to the potential for limited information and regulatory oversight.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure due to OTC Other listing.
- High price volatility and potential for manipulation.
- Risk of delisting or trading suspension.
- Limited liquidity and wide bid-ask spreads.
- Potential for fraud or mismanagement.
- Verify the company's financial statements and SEC filings (if any).
- Assess the company's management team and their track record.
- Evaluate the company's business model and competitive landscape.
- Review the company's legal and regulatory compliance.
- Analyze the company's debt and cash flow situation.
- Monitor news and press releases for updates on the company's restructuring efforts.
- Consult with a financial advisor before investing.
- Established history since 1969.
- Operation of the SleepMaster Solutions program.
- Presence in the healthcare sector.
- Continued efforts to restructure after bankruptcy.
- Existence of a subsidiary, Pharmacy Value Management Solutions, Inc.
Haeufige Fragen zu CHCR
What are the key factors to evaluate for CHCR?
Advanzeon Solutions, Inc. (CHCR) currently holds an AI score of 46/100, indicating low score. Key strength: Specialized SleepMaster Solutions program.. Primary risk to monitor: Ongoing: Financial instability due to Chapter 11 bankruptcy.. This is not financial advice.
How frequently does CHCR data refresh on this page?
CHCR prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CHCR's recent stock price performance?
Recent price movement in Advanzeon Solutions, Inc. (CHCR) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Specialized SleepMaster Solutions program.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CHCR overvalued or undervalued right now?
Determining whether Advanzeon Solutions, Inc. (CHCR) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CHCR?
Before investing in Advanzeon Solutions, Inc. (CHCR), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding CHCR to a portfolio?
Potential reasons to consider Advanzeon Solutions, Inc. (CHCR) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Specialized SleepMaster Solutions program.. Additionally: Experience in sleep apnea program administration.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of CHCR?
Yes, most major brokerages offer fractional shares of Advanzeon Solutions, Inc. (CHCR) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track CHCR's earnings and financial reports?
Advanzeon Solutions, Inc. (CHCR) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CHCR earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Information is limited due to the company's OTC listing and bankruptcy filing.
- Financial data may not be readily available or reliable.
- Analyst coverage is unlikely given the company's financial condition.